PMNProMIS Neurosciences Inc.

Nasdaq promisneurosciences.com


$ 1.70 $ -0.04 (-2.14 %)    

Friday, 07-Jun-2024 11:36:19 EDT
QQQ $ 485.75 $ 5.79 (1.21 %)
DIA $ 388.52 $ 3.46 (0.9 %)
SPY $ 547.57 $ 5.49 (1.01 %)
TLT $ 93.66 $ -0.20 (-0.21 %)
GLD $ 214.40 $ -0.48 (-0.22 %)
$ 1.6133
$ 1.70
$ 0.00 x 0
$ 0.00 x 0
$ 1.70 - $ 1.70
$ 0.95 - $ 8.95
3,270
na
31.51M
$ 17.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-08-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 promis-neurosciences-q1-2024-adj-eps-019-beats-020-estimate

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.8...

 promis-neurosciences-q4-eps-009-beats-017-estimate

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $...

 promis-neurosciences-reveals-strengthening-of-global-intellectual-property-portfolio

The European Patent Office, Japanese Patent Office and IP Australia, the Australian patent office, have recently allowed compos...

 why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

 promis-neurosciences-q3-eps-019-up-from-085-yoy

ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.19) per share. This is a 77.65 percent increase over losses ...

 btig-initiates-coverage-on-promis-neurosciences-with-buy-rating-announces-price-target-of-8

BTIG analyst Thomas Shrader initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Buy rating and announces Price Ta...

 promis-neurosciences-inc-files-for-shelf-of-up-to-221m-common-shares-by-selling-stockholders

- Sec Filing

 crude-oil-falls-dicks-sporting-goods-earnings-miss-views

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling over 100 points on Tuesday. The Dow trad...

 why-macys-are-trading-lower-by-around-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the co...

 why-promis-neurosciences-shares-are-trading-higher-by-33-here-are-20-stocks-moving-premarket

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. T...

Core News & Articles

FULC: 60% | FDA Lifts Clinical Hold on Fulcrum Therapeutics' FTX-6058 for Sickle Cell Disease PMN: 52% | ProMIS Neuroscien...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 155 companies set new 52-week lows.

 why-biophytis-shares-are-trading-higher-by-54-here-are-20-stocks-moving-premarket

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partners...